Cellectis
CLLS
69 hedge funds and large institutions have $222M invested in Cellectis in 2018 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 10 closing their positions.
120% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 10
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
22% more call options, than puts
Call options by funds: $1.42M | Put options by funds: $1.17M
21% more funds holding
Funds holding: 57 → 69 (+12)
4% more capital invested
Capital invested by funds: $213M → $222M (+$9.09M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.01% less ownership
Funds ownership: 20.63% → 19.63% (-1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Nexthera Capital
New York
|
+$10.5M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$5.07M |
| 3 |
AC
Ascend Capital
Orinda,
California
|
+$3.92M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.21M |
| 5 |
Jane Street
New York
|
+$1.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$11.9M |
| 2 |
Morgan Stanley
New York
|
-$7.69M |
| 3 |
PC
PointState Capital
New York
|
-$4.24M |
| 4 |
AG
Artal Group
Luxembourg
|
-$2.92M |
| 5 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$2.85M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$4K | -140 | Closed |
|
|
RE
77
RBC Europe
London,
United Kingdom
| – | -$3.76K | -129 | Closed |
|
|
II
78
Inspire Investing
Meridian,
Idaho
| – | -$1K | -43 | Closed |
|
CLLS Hedge Fund Activity: Q1 2018 in Review
69 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2018, worth a combined $222M — up 4.3% from $213M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CLLS positions and 10 closed out — a net gain of 12 holders — while 19 added to existing stakes and 15 trimmed.
The largest buyer was Nexthera Capital, opening a new position worth an estimated $10.5M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $11.9M sold.
- 69 institutional investors held Cellectis (CLLS) as of Q1 2018, up from 57 in Q4 2017.
- Funds reported $222M of Cellectis stock for Q1 2018, up 4.3% quarter-over-quarter.
- 22 funds opened new Cellectis positions in Q1 2018 and 10 closed out, a net change of +12 holders.
- The largest Cellectis buyer in Q1 2018 was Nexthera Capital, an estimated $10.5M added.
- The largest Cellectis seller in Q1 2018 was Balyasny Asset Management, an estimated $11.9M sold.
Based on aggregated 13F filings for Q1 2018.